Heart Failure
Conference Coverage
ESC: Noncardiac surgery in HCM patients warrants special attention
Hypertrophic cardiomyopathy patients undergoing noncardiac surgery have significantly worse outcomes than do matched controls undergoing similar...
Conference Coverage
ESC: Further data indicate no excess heart failure risk with lixisenatide or sitagliptin
Key clinical point:Patients with type 2 diabetes who are treated with lixisenatide or sitagliptin are at no greater risk for heart failure than if...
Conference Coverage
ESC: Heart failure risk climbs early in childhood cancer survivors
Survivors of childhood cancer face a heart failure risk that grows with time but is already elevated by age 20.
Conference Coverage
ESC: Zero risk of death in pregnant women with severe aortic stenosis
Pregnancy in women with moderate or severe aortic stenosis now carries a near-zero maternal mortality risk.
Conference Coverage
VIDEO: Patients use CardioMEMS feedback to improve self-management
Conference Coverage
ESC: Most heart failure patients’ rehospitalizations are for other reasons
Key clinical point: Hospital readmission in patients with heart failure is often a result of noncardiovascular causes, warranting a...
News
Collaboration helped reduce heart failure readmissions
Hospitals that participated in the Southeast Michigan “See You in 7 Collaborative” experienced substantial reductions in 30-day readmission rates...
Conference Coverage
ESC: CERTITUDE casts doubt on defibrillator benefit in CRT
Key clinical point:There appears to be no survival benefit of cardiac resynchronization therapy with a defibrillator CRT-D over a pacemaker (CRT-P...
Conference Coverage
VIDEO: Adverse ventilation effect means rethinking Cheyne-Stokes respiration
Commentary
Heart failure’s surprises keep coming
Heart failure continues to reveal its mysteries slowly and reluctantly. Clinicians who believe they know all they need to about how to safely and...
Conference Coverage
ESC: New review yields reassuring digoxin data
Key clinical point: Digoxin remains safe and effective in patients with heart failure and/or atrial fibrillation, according to a major new review...